Co-immunoprecipitation (co-IP) assays showed that both ectopically expressed and endogenous TRABID interacted with 53BP1 in 293 T cells and PC-3 prostate cancer cells (Fig. 2a, b). The gene discussed is TP53BP1; the disease is prostate cancer.